<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116080">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02020668</url>
  </required_header>
  <id_info>
    <org_study_id>Mac/NMP 1210</org_study_id>
    <nct_id>NCT02020668</nct_id>
  </id_info>
  <brief_title>Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient</brief_title>
  <official_title>Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Macmillan Research Group UK</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NMP Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Warwick Research Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Macmillan Research Group UK</source>
  <oversight_info>
    <authority>India: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite leading cause of morbidity,  treatment strategies for Rheumatic diseases are geared
      almost exclusively toward medical-pharmacological area away from offering the patient the
      possibility of an interdisciplinary approach to their disease.

      Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in
      rheumatic disease and improve their quality of life related to health.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Change from baseline in  Numerical Scale Downie at 16 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Change from Baseline in Short Form (SF) 36 at 16 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Functional capacity</measure>
    <time_frame>Change from baseline in Barthel Index at 16 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Rheumatic Arthritis</condition>
  <arm_group>
    <arm_group_label>Physiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Physiotherapy included  joint protection strategies, performance of therapeutic exercises and patient education.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait list control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Wait list control received standard care and were invited to join the physiotherapy once intervention period is finished.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiotherapy</intervention_name>
    <arm_group_label>Physiotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wait list control</intervention_name>
    <arm_group_label>Wait list control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years

          -  History of Rheumatoid Arthritis (RA) symptoms for less than 7 years

          -  Had RA by American College of Rheumatology (ACR) criteria

          -  ACR functional RA class I, II or III

          -  Hemoglobin more than 8g/dL without evidence of active bleeding

          -  Positive for rheumatoid factor (RF)  or anti cyclic citrullinated protein

          -  standard conventional medicine were allowed within the approved dosage regimen

        Exclusion Criteria:

          -  connective tissue disease

          -  any other alternative or complementary medicine with in last 3 months.

          -  corticosteroid, disease modifying medicines

          -  Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases,
             carcinoma, drug abuse
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neha Sharma, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Macmillan Research Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Om Prakash Sharma, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Life Line Hospital, Sikar, India</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Virendra Shekhawat, MA</last_name>
    <phone>+91-8824260512</phone>
    <email>shekhawatvans21@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Life Line Hospital</name>
      <address>
        <city>Sikar</city>
        <state>Rajasthan</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Deepika Ratan</last_name>
      <phone>9413623113</phone>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>December 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Functional capacity</keyword>
  <keyword>Quality of Life</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Rheumatic Fever</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
